For additional reading on mucosal DDS, in my next chapter, I shall present a list of references that may be useful to give more insight into this delightful topic.
De Campos A.M.;Diebold Y.;Carvalho E.L.S.;Sánchez A.,José Alonso M. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharmaceutical Research, Springer. 2004; 21(5): 803-810(8).
Alvarez-Lorenzo, C., Hiratani, H., & Concheiro, A. (2006). Contact lenses for drug delivery: Achieving sustained release with novel systems. American Journal of Drug Delivery, 4, 131-151.
American Heart Association. (2005). Management of cardiac arrest recommended by the American Heart Association. Retrieved June 23, 2008, from http://circ.ahajournals.org/cgi/ content/full/112/24_suppl/IV-58
Bajwa, Z., & Warfield, C. (2008). Interventional approaches to the management of cancer pain. Retrieved on May 13, 2008, from www.uptodate.com
Bielinska, A., Janxzak, K., & Landers, J. (2008). Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Thl polarized responses and neutralizing antibodies to primary HIV type isolates. AIDS Research and Human Retroviruses, 24, 271-281.
Bulletin Board. (2008). Nanomedicine, 3, 145-147.
Canadian Press. (2008). Canadian researchers develop automated anesthesia system dubbed McSleepy. Retrieved May 6, 2008, from www.googlenews.com
Chandhari, M., & Mackenzie, P. (2007). Implantable technology for pain management. Anaesthesia & Intensive Care Medicine, 9, 69-74.
Clinical Trials. (2008, February). BioDelivery sciences to present BEMA fentanyl data at the 24th Annual Meeting of the American Academy of Pain Medicine. Retrieved on May 15, 2008, from http://www.drugs.corn/clinical_trials/biodeliverysciences-present- bema-fentanyl-data-24t
Cox, C. (n.d.). Treatment options gel with innovative drug delivery systems. Drug Delivery Technology Retrieved on May 16, 2008, from http://www.drugdeliverytech.com/cgi-bin/articles. cgi?idArticle=55
Gotfried, M. H., Shaw, J. P., Benton, B. M., Krause, K. M., Goldberg, M. R., Kitt, M. M., et al. (2008). Intrapulmonary distribution of intravenous televancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of televancin and other antibiotics. Antimicrobial Agents and Chemotherapy, 52, 92-97.
Hafeli, U. (2004). Magnetically modulated therapeutic systems. International Journal of Pharmaceutics, 277, 19-24.
Hirlekar, R., Patel, P, & Dand, N. (2008). Drug loaded erythrocytes: As novel drug delivery system. Current Pharmaceutical Design, 14, 63 70.
in-Pharma Technologist.com. (January 10, 2005). Contact lenses deliver drugs to eye. Retrieved on May 30, 2008, from http:// www.in-pharmatechnologist.com/news/ng.asp?id=57187-contact-lenses-deliver
Irani, F., Dankert, M., Brensinger, C., Bilker, W., Nair, S., Kohler, C., et al. (2004). Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology, 29, 960-968.
De Campos A.M.;Diebold Y.;Carvalho E.L.S.;Sánchez A.,José Alonso M. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharmaceutical Research, Springer. 2004; 21(5): 803-810(8).
Alvarez-Lorenzo, C., Hiratani, H., & Concheiro, A. (2006). Contact lenses for drug delivery: Achieving sustained release with novel systems. American Journal of Drug Delivery, 4, 131-151.
American Heart Association. (2005). Management of cardiac arrest recommended by the American Heart Association. Retrieved June 23, 2008, from http://circ.ahajournals.org/cgi/ content/full/112/24_suppl/IV-58
Bajwa, Z., & Warfield, C. (2008). Interventional approaches to the management of cancer pain. Retrieved on May 13, 2008, from www.uptodate.com
Bielinska, A., Janxzak, K., & Landers, J. (2008). Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Thl polarized responses and neutralizing antibodies to primary HIV type isolates. AIDS Research and Human Retroviruses, 24, 271-281.
Bulletin Board. (2008). Nanomedicine, 3, 145-147.
Canadian Press. (2008). Canadian researchers develop automated anesthesia system dubbed McSleepy. Retrieved May 6, 2008, from www.googlenews.com
Chandhari, M., & Mackenzie, P. (2007). Implantable technology for pain management. Anaesthesia & Intensive Care Medicine, 9, 69-74.
Clinical Trials. (2008, February). BioDelivery sciences to present BEMA fentanyl data at the 24th Annual Meeting of the American Academy of Pain Medicine. Retrieved on May 15, 2008, from http://www.drugs.corn/clinical_trials/biodeliverysciences-present- bema-fentanyl-data-24t
Cox, C. (n.d.). Treatment options gel with innovative drug delivery systems. Drug Delivery Technology Retrieved on May 16, 2008, from http://www.drugdeliverytech.com/cgi-bin/articles. cgi?idArticle=55
Gotfried, M. H., Shaw, J. P., Benton, B. M., Krause, K. M., Goldberg, M. R., Kitt, M. M., et al. (2008). Intrapulmonary distribution of intravenous televancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of televancin and other antibiotics. Antimicrobial Agents and Chemotherapy, 52, 92-97.
Hafeli, U. (2004). Magnetically modulated therapeutic systems. International Journal of Pharmaceutics, 277, 19-24.
Hirlekar, R., Patel, P, & Dand, N. (2008). Drug loaded erythrocytes: As novel drug delivery system. Current Pharmaceutical Design, 14, 63 70.
in-Pharma Technologist.com. (January 10, 2005). Contact lenses deliver drugs to eye. Retrieved on May 30, 2008, from http:// www.in-pharmatechnologist.com/news/ng.asp?id=57187-contact-lenses-deliver
Irani, F., Dankert, M., Brensinger, C., Bilker, W., Nair, S., Kohler, C., et al. (2004). Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology, 29, 960-968.
